Updated heart guidelines urge earlier screening for high blood cholesterol
For the first time since 2018, a clinical guideline from the American College of Cardiology and the American…
New algorithm enables precise subtyping of metabolic liver disease
Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes affecting more than 30%…
Scientists Say This Nut Boasts Major Anti-Aging Benefits
This article contains affiliate links; if you click such a link and make a purchase, we may earn…
The lifelong cardiovascular impact of placental abruption
Rutgers Health research shows the risk of developing early cardiovascular disease or dying from cardiovascular disease by the…
Scientists Say This Nut Boasts Major Anti-Aging Benefits
This article contains affiliate links; if you click such a link and make a purchase, we may earn…
Yogurt, cheese, and chocolate consumption is tied to reduced mortality risk, researchers report
Could everyday foods like yogurt and chocolate quietly shape how long we live? A sweeping global analysis reveals…
Researchers use multiview deep learning to enhance echocardiogram analysis
Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global health priority. An echocardiogram,…
I’m a cardiologist — 3 great supplements for your heart and 4 to avoid
An image collage containing 3 images, Image 1 shows A woman pours light blue pills from a white…
Can eating almonds reduce inflammation in obesity?
A six-week randomized trial shows that adding almonds to the daily diet of adults with obesity can improve…
Higher intake of ultra processed foods linked to weaker bones
From flavored yogurts to frozen pizzas, breakfast cereals and instant oats, ultra-processed foods are convenient, often cheaper items…
Cannabis, cocaine and amphetamines linked to higher stroke risk
A massive analysis of more than 100 million participants reveals that several commonly used illicit substances may raise…
Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal
Alnylam Pharmaceuticals has forged a discovery collaboration worth up to $1.23bn with cardiovascular disease specialist, Tenaya Therapeutics. Through…